ライフサイエンスコーパス: chest pain

1 T) might improve evaluation of patients with chest pain.

2 ial disease and a relatively common cause of chest pain.

3 drome in patients presenting with exertional chest pain.

4 ive to triage patients presenting with acute chest pain.

5 itted to this hospital because of fevers and chest pain.

6 to PCI complications but often for recurrent chest pain.

7 n important and often overlooked etiology of chest pain.

8 rthralgia, diarrhea, pruritus, vomiting, and chest pain.

9 tment (ED) evaluation in patients with acute chest pain.

10 fractory asthma, especially those presenting chest pain.

11 who present to the emergency department with chest pain.

12 sive coronary angiography and FFR for stable chest pain.

13 detection of the cause of death after acute chest pain.

14 eafter in 887 unselected patients with acute chest pain.

15 agia relief, 83% having relief of noncardiac chest pain.

16 greater than 1, due to persistent noncardiac chest pain.

17 d intermediate-risk patients presenting with chest pain.

18 ation period required for some patients with chest pain.

19 d bedside evaluation of patients with recent chest pain.

20 sed to predict MEs in patients with ischemic chest pain.

21 ng (MPI) in the evaluation of acute low-risk chest pain.

22 1 [standard deviation]; 33% male) with acute chest pain.

23 (ACS) in emergency department patients with chest pain.

24 dpoints were total exercise time and time to chest pain.

25 and assessment of prognosis in patients with chest pain.

26 as part of the clinical evaluation of stable chest pain.

27 value (PPV) of 100% for detecting causes of chest pain.

28 enting to the emergency department (ED) with chest pain.

29 selection of noninvasive testing for stable chest pain.

30 ame, which resulted in the resolution of her chest pain.

31 e diagnostic pathway of patients with stable chest pain.

32 al care over 90 days in patients with stable chest pain.

33 ncy department with left-sided abdominal and chest pain.

34 nd 12-month mortality in patients with acute chest pain.

35 for management of low- to intermediate-risk chest pain, 120 individuals were randomly assigned to re

36 1), and those without a primary complaint of chest pain (3.5 minutes; P<0.01).

37 for visit were pneumonia (4.5%), nonspecific chest pain (3.7%), and urinary tract infection (3.2%).

38 ; 70% shortness of breath; 47% wheezing; 46% chest pain; 42% abnormal peak flow), 334 (84%) provided

39 weeks (11% versus 9%), dysphagia/odynophagia/chest pain (9% versus 2%), strictures (0% versus 0%), an

40 osis is based on clinical criteria including chest pain, a pericardial rub, electrocardiographic chan

41 ow- to intermediate-risk patients with acute chest pain, a positive ETT has a limited sensitivity but

42 Eighteen patients with syndrome X (chest pain, abnormal exercise treadmill test, normal cor

43 o-apply instrument to stratify patients with chest pain according to their short-term risk for major

44 phy (CTA) for evaluating patients with acute chest pain (ACP).

45 ed to evaluate the need for reevaluation for chest pain, additional imaging, or cardiac events.

46 ormed in 760 consecutive patients with acute chest pain admitted thorough the emergency department.

47 ased on the clinical picture of retrosternal chest pain, aided by electrocardiographic findings of ST

48 noninvasive testing for patients with stable chest pain, although many subsequently have normal test

49 t for 60-year-old patients who have nonacute chest pain and a low to intermediate probability of CAD.

50 fferential diagnosis in a young patient with chest pain and an abnormal ECG.

51 patients (mean age, 53.0+/-10.1 years) with chest pain and angiographically nonsignificant coronary

52 ociated with reported functional impairment, chest pain and anxiety, but not illness severity or pati

53 lter monitoring revealed ST elevation during chest pain and coronary angiography showed coronary vaso

54 Subjects were adults with chest pain and dyspnea, nondiagnostic ECGs, and no obvio

55 dly obese patients presenting to the ED with chest pain and dyspnea.

56 posure in patients presenting to the ED with chest pain and dyspnea.

57 nd length of hospital stay for patients with chest pain and dyspnea.

58 al with productive cough, fever, hemoptysis, chest pain and dyspnea.

59 % of men vs. 53% of women; P = 0.59), mainly chest pain and dyspnea.

60 singly used technique for initial work-up of chest pain and early post-reperfusion and follow-up eval

61 There is a high incidence of pericarditic chest pain and ECG changes after epicardial ventricular

62 year-old man who presented with weight loss, chest pain and epigastric pain was found to have pericar

63 Two elotuzumab-related serious AEs of chest pain and gastroenteritis occurred in one patient.

64 omen presented more frequently with atypical chest pain and had a lower pretest probability of corona

65 ll patients who sought medical attention for chest pain and had at least 1 hs-cTnT analyzed during 2

66 were more likely than men to present without chest pain and had higher mortality than men within the

67 patients (N = 22,589) >25 years of age with chest pain and hs-cTnT analyzed concurrently in the emer

68 differences in clinical presentation without chest pain and in mortality were attenuated with increas

69 A total of 475 patients with stable chest pain and intermediate likelihood of CAD underwent

70 luation of Chest Pain), patients with stable chest pain and intermediate pretest probability for obst

71 European population of patients with stable chest pain and low prevalence of CAD, coronary computed

72 eviation]; 58% were male) with ischemic-type chest pain and low to intermediate risk for ACS were eva

73 A 60-year-old woman with recent chest pain and no history of previous disease was admitt

74 nstrate its role in evaluating patients with chest pain and nonobstructive coronary artery disease.

75 0-day MACE in a majority of ED patients with chest pain and performed better than the troponin-alone

76 In patients with stable chest pain and planned invasive coronary angiography, ca

77 Six hundred patients with chest pain and previous revascularization included in a

78 aging outcome trials in patients with stable chest pain and provide significant insights into patient

79 Postoperative long-term residual chest pain and pulmonary function were comparable in bot

80 /minocycline group had a higher intensity of chest pain and required more frequent meperidine injecti

81 ered Nurses during two simulation exercises (chest pain and respiratory distress); (b) video footage

82 d a pain in her tail bone, and one woman had chest pain and shortness of breath).

83 Among patients with chest pain and stable troponin levels, any detectable le

84 ts with abdominal pain (15%), 53 of 387 with chest pain and/or dyspnea (14%), and 49 of 433 with head

85 ts with abdominal pain (25%), 72 of 387 with chest pain and/or dyspnea (19%), and 81 of 426 with head

86 s with abdominal pain (51%), 163 of 387 with chest pain and/or dyspnea (42%), and 103 of 433 with hea

87 pectively, for patients with abdominal pain, chest pain and/or dyspnea, and headache; P < .0001); med

88 ho were referred for CT with abdominal pain, chest pain and/or dyspnea, or headache were identified.

89 reported a combination of effort and resting chest pain, and 41 (4%) presented with troponin-positive

90 to deterioration of the composite of cough, chest pain, and dyspnoea in the QLQ-LC13.

91 Duke score, including ST-segment depression, chest pain, and exercise capacity, was used as the outco

92 idered when patients present with dysphagia, chest pain, and refractory reflux symptoms after an endo

93 patients are given a diagnosis of noncardiac chest pain, and some are considered to have microvascula

94 hospital mortality than younger men without chest pain, and these sex differences decreased or even

95 ads to symptoms of dysphagia, regurgitation, chest pain, and weight loss, but also results in an incr

96 and vomiting; one had malaise, headache, and chest pain; and one had severe chest pain, difficulty br

97 reasons for readmission included nonspecific chest pain/angina (24%) and heart failure (11%).

98 re emergency department evaluation for acute chest pain annually at an estimated diagnostic cost of >

99 Most patients with chest pain are discharged from the emergency department

100 About 10% of patients with acute chest pain are ultimately diagnosed with acute coronary

101 Women describe their chest pain as sharp and stabbing, while men have chest p

102 male; mean age, 55 years +/- 11) with acute chest pain at low to intermediate risk for coronary arte

103 ificant interaction between age and sex with chest pain at presentation, with a larger sex difference

104 ee hundred forty-six patients (35%) reported chest pain at rest, 222 (22%) reported chest pain on exe

105 One of 10 serious adverse events (chest pain, brinzolamide group) was judged as treatment

106 hs-cTn) levels and outcomes in patients with chest pain but no myocardial infarction (MI), or any oth

107 patients (mean age, 53.0+/-10.3 years) with chest pain but no prior coronary intervention served as

108 In emergency department patients with acute chest pain, CAC score does not provide incremental value

109 ement detailed clinical assessment including chest pain characteristics and the electrocardiogram.

110 The Chest Pain Choice trial was a prospective randomized eva

111 with syndrome X show greater sensitivity to chest pain compared with controls but no evidence of deo

112 d both can present with shortness of breath, chest pain, cough, and wheezing.

113 agnostic protocol (ADP) for possible cardiac chest pain could identify low-risk patients suitable for

114 formance of circulating MPO in patients with chest pain (CP) are mainly retrospective, of low size, a

115 ography (CA) for diagnosis and management of chest pain (CP) has several flaws.

116 headache, and chest pain; and one had severe chest pain, difficulty breathing, and left arm pain) and

117 ovascular (CV) risk profile in patients with chest pain discharged from the ED.

118 y included 65,696 patients with "unspecified chest pain" discharged from 16 Swedish hospital EDs betw

119 rdiovascular disease, who were evaluated for chest pain, discharged, and without adverse clinical out

120 n (MI) and also present less frequently with chest pain/discomfort.

121 fect, chronic obstructive pulmonary disease, chest pain, diverticulitis, enterovesical fistula, gastr

122 Patients presenting with chest pain due to suspected ACS were included.

123 09 (age, 59 years; 30% women; 19% uninsured; chest pain duration, 91 minutes; shock, 9.2%).

124 ents with syndrome X (17/18 [94%]) developed chest pain during adenosine stress than controls (6/14 [

125 hine oxidase inhibitor, prolongs the time to chest pain during exercise in angina.

126 There were 21,742 patients evaluated for chest pain during the study period.

127 more prevalent in women than men, functional chest pain, dyspepsia, vomiting, and anorectal pain do n

128 symptomatic diagnoses including non-specific chest pain, dyspnoea and syncope (1368 [6%] deaths), and

129 resents with non-specific symptoms including chest pain, dyspnoea, and palpitations, it often mimics

130 on admission; headache/visual disturbances; chest pain/dyspnoea; vaginal bleeding with abdominal pai

131 rolled well and their symptoms including the chest pain eroded their quality of life.

132 udy, we prospectively enrolled patients with chest pain, evaluating them with standard troponin T and

133 ients undergoing coronary CT angiography for chest pain evaluation is associated with a small reducti

134 ajor adverse cardiac events, repeat hospital chest pain evaluation, and repeat imaging or stress test

135 ctly discharged from the ED with unspecified chest pain experienced fewer MACEs and had a better risk

136 ted tomographic angiography caused by stable chest pain, expert readers identified 30 patients with N

137 ify emergency department patients with acute chest pain for early discharge.

138 d age-specific odds ratios (ORs) for lack of chest pain for women (referent, men) were younger than 4

139 enting to the emergency department (ED) with chest pain, for whom hs-cTnT testing was ordered at pres

140 Multicenter Imaging Study for Evaluation of Chest Pain) found that initial use of at least 64-slice

141 y group were dyspnoea (four [15%] patients), chest pain (four [15%] patients), and lung infections (t

142 Allopurinol increased the time to chest pain from a baseline of 234 s (IQR 189-382) to 304

143 cy Medical System runsheets of patients with chest pain from January 2003 to April 2008 were analyzed

144 nting to the emergency department with acute chest pain from July 19, 2013, to December 31, 2014.

145 Younger women presenting without chest pain had greater hospital mortality than younger m

146 nths, their asthma, including the symptom of chest pain, improved.

147 ted with pneumonia; however, the presence of chest pain in 2 studies that included adolescents was as

148 val, 14%-17%) and was accompanied by typical chest pain in 24 of 397 patients (6%) and any ischemic s

149 he emergency department after evaluation for chest pain in Ontario, follow-up with a cardiologist was

150 is useful to rule out other causes of acute chest pain in patients admitted to the emergency departm

151 graphy (2D-TTE) to determine causes of acute chest pain in patients presenting to the ED in order to

152 The pathophysiology of chest pain in patients with cardiac syndrome X remains c

153 CCTA) versus usual care (UC) triage of acute chest pain in the emergency department (ED).

154 CTA in the evaluation of patients with acute chest pain in the Rule Out Myocardial Infarction Using C

155 old female who presented with non-exertional chest pain in the setting of an emotional stressor.

156 individuals with intermediate- to high-risk chest pain, in those with lower-risk chest pain, these r

157 Use of a decision aid in patients with chest pain increased knowledge and engagement in decisio

158 Readmissions with recurrent chest pain infrequently met criteria for myocardial infa

159 age >60 years, rapid deceleration mechanism, chest pain, intoxication, abnormal alertness/mental stat

160 Chest pain is a common symptom often associated with ben

161 Chest pain is a leading reason patients seek medical eva

162 Hospital evaluation of patients with chest pain is common and costly.

163 The routine use of CCTA for ED evaluation of chest pain is feasible and safe.

164 Assessment of chest pain is one of the most common reasons for emergen

165 Emergency department diagnosis of chest pain is problematic, often requiring prolonged obs

166 diate risk of ACS who present to the ED with chest pain is safe at long-term follow-up, including pat

167 e during initial assessment of patients with chest pain is safe, but the effect on health care resour

168 Pericarditic chest pain is significantly decreased by intrapericardia

169 al imaging strategy for patients with stable chest pain is uncertain.

170 artment (ED) with the diagnosis "unspecified chest pain." It is unknown if evaluation with a high-sen

171 For example, women experience chest pain less frequently than men.

172 Chest pain, lower New York Heart Association class, high

173 In early presenters (chest pain <3 h), the improvement in rule-in/rule-out cl

174 Obtaining a PH ECG for patients with chest pain minimally prolongs scene and transport times.

175 clinicians discussing treatment options for chest pain, myocardial infarction, diabetes mellitus, an

176 ts were neutropenia (n = 5), nausea (n = 2), chest pain (n = 2), deep vein thrombosis (n = 1), transa

177 46%), followed by dysphagia (n = 4, 37%) and chest pain (n = 2, 18%).

178 ndertaken in patients with spontaneous acute chest pain (n = 30).

179 pe or presyncope, focal neurologic deficits, chest pain, nausea, vomiting, unintentional weight loss,

180 r the curve 0.94) and in patients with acute chest pain (negative predictive value 95%).

181 DHE was added to a model that included age, chest pain, New York Heart Association class, and Wester

182 t pain unit for patients admitted with acute chest pain, nondiagnostic ECG, and negative 12-hour trop

183 Patients were adults with dyspnea and chest pain, nondiagnostic electrocardiograms, and no obv

184 category of biomarker elevation with neither chest pain nor ECG abnormality was prespecified (biomark

185 ad a very low likelihood of disease, with no chest pain, normal relative perfusion results, and norma

186 gnificant portion of women veterans may have chest pain not attributable to obstructive coronary arte

187 e (odds ratio, 0.73 [95% CI, 0.55 to 0.96]), chest pain (odds ratio, 0.63 [CI, 0.44 to 0.89]), septic

188 on scene-to-hospital time for patients with chest pain of cardiac origin and those with ST-segment e

189 coronary angiography for evaluation of acute chest pain of coronary origin in non-diabetic patients.

190 orted chest pain at rest, 222 (22%) reported chest pain on exertion, 238 (24%) reported a combination

191 The 3-way interaction (sex, age, and chest pain) on mortality was significant (P < .001).

192 cted from 92 AMI patients within 48 hours of chest pain onset and 105 asymptomatic healthy control in

193 Shortening the duration between chest pain onset and reperfusion to less than 4.0 hours

194 Patients presenting within 3 hours of chest pain onset had elevated levels of hypoxia inducibl

195 The results showed that time from chest pain onset to door did not differ between two grou

196 /-8.3 years, 52.7% were women, and 87.7% had chest pain or dyspnea on exertion.

197 tion with exercise-related anginal symptoms (chest pain or dyspnea) with or without occasional attack

198 s defined as biomarker elevation plus either chest pain or ECG evidence of ischemia.

199 For cases in which chest pain or other symptoms concerning for angina promp

200 were readmitted for evaluation of recurrent chest pain or other symptoms concerning for angina, wher

201 luation of Chest Pain), patients with stable chest pain (or dyspnea) and intermediate pretest probabi

202 er/chills/night sweats, dyspnea or pleuritic chest pain) or with Pneumonia-in-Plan (adds pneumonia st

203 ce of pericarditic ECG changes, pericarditic chest pain, or pericarditis (all P>0.05).

204 lated adverse events involving palpitations, chest pain, or tachycardia, and 58.0% (95% CI, 52.2 to 6

205 ction, hospital admission for heart failure, chest pain, other angina, and subdural or extradural hae

206 In conclusion, when a patient presents with chest pain, our carrying out LDH and D-Dimer tests will

207 y of heart disease (P < 0.001) or continuous chest pain (P < 0.001).

208 y department with complaints of intermittent chest pain, palpitations and exertional dyspnoea.

209 Exertional dyspnea, chest pain, palpitations, and ankle swelling were report

210 Typical symptoms include dyspnoea, chest pain, palpitations, and syncope.

211 The majority of chest pain patients (288; 84.4%) underwent >/=1 diagnost

212 independently associated with MACE in acute chest pain patients and beyond that provided by clinical

213 d tomographic angiography (CCTA) in triaging chest pain patients in the emergency department (ED).

214 f hs-TnT reporting on care and outcome among chest pain patients presenting to 5 emergency department

215 l was an observational cohort study of acute chest pain patients presenting to the emergency departme

216 c Angiography for Systematic Triage of Acute Chest Pain Patients to Treatment [CT-STAT]; NCT00468325)

217 can be performed in more than two thirds of chest pain patients without a high pretest probability o

218 However, compared with chest pain patients, in STEMI patients (n = 303), shorte

219 In emergency department acute, low-risk chest pain patients, the use of CCTA results in more rap

220 ry CTA strategy to standard of care in acute chest pain patients.

221 Multicenter Imaging Study for Evaluation of Chest Pain), patients with stable chest pain (or dyspnea

222 Multicenter Imaging Study for Evaluation of Chest Pain), patients with stable chest pain and interme

223 on the presence of 2 of 4 clinical criteria (chest pain, pericardial rubs, widespread ST-segment elev

224 Chest pain persisted despite administration of a coronar

225 cCTA may be a cost-saving tool in acute chest pain populations that have a prevalence of potenti

226 Unselected patients with chest pain presenting at emergency departments in 2013 a

227 s was a 16-site study in 1,967 patients with chest pain presenting to an ED within 6 hours of pain on

228 estive heart failure and a 1-week history of chest pain, progressive dyspnea, abdominal swelling, bip

229 Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) trial found that initial use of >/=

230 Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) trial, readers at 193 North America

231 Multicenter Imaging Study for Evaluation of Chest Pain [PROMISE]) includes stable, symptomatic outpa

232 Chest pain, pulmonary embolus, and mental status change

233 Chest pain, pulmonary embolus, and mental status change

234 ference in the rate of admission for cardiac chest pain (rate ratio, 1.21; 95% confidence interval, 0

235 In patients with lower-risk chest pain receiving emergency department-directed OU ca

236 The routine use of CCTA in ED evaluation of chest pain reduces healthcare resource utilization.

237 ctice, more than 25% of patients with stable chest pain referred for noninvasive testing will have no

238 Optimal management of patients with stable chest pain relies on the prognostic information provided

239 in emergency department patients with acute chest pain remains unsettled.

240 Multicenter Imaging Study for Evaluation of chest pain) represent the 2 largest and most comprehensi

241 ent's troponins began to trend down, and her chest pain resolved.

242 oman was admitted to the hospital because of chest pain, respiratory distress, and a purpuric rash.

243 R 2.46, 95% CI 1.21, 4.98) and self-reported chest pain (RRR 2.24, 95% CI 1.34, 3.77) were associated

244 ens 1.5-T Avanto scanner in 41 subjects with chest pain scheduled for coronary angiography.

245 steps were more likely to be omitted in the chest pain simulation, for which there was a hospital pr

246 ent in at least two of four symptoms (cough, chest pain, sputum production, dyspnoea) with no worseni

247 ith or without occasional attacks of resting chest pain suggestive of coronary artery disease, 40% of

248 scene and transport times for patients with chest pain suspected of cardiac origin.

249 asingly being used to evaluate patients with chest pain symptoms.

250 n concentrations in patients presenting with chest-pain symptoms and being investigated for possible

251 een deemed appropriate for the evaluation of chest pain syndromes in patients with intermediate proba

252 y adopted in the management of subjects with chest pain syndromes.

253 een the many conditions that can cause acute chest pain syndromes.

254 of patients presenting to the ED with acute chest pain syndromes; however, the impact of such testin

255 ity of readmissions were because of low-risk chest pain that did not require any intervention.

256 t pain as sharp and stabbing, while men have chest pain that is felt as a pressure or heaviness.

257 sited our hospital complaining of persistent chest pain that manifested in the evenings and early mor

258 elop constitutional symptoms or sudden onset chest pain that start days or weeks after atrial fibrill

259 des valuable information about patients with chest pain, there is growing concern regarding its radia

260 95% CI: 0.4%, 2.3%) had been readmitted for chest pain; there were no instances of coronary revascul

261 gh-risk chest pain, in those with lower-risk chest pain, these results highlight the importance of ph

262 d cohorts of 894 ED patients presenting with chest pain to assess the impact of CCTA versus standard

263 Further analysis showed that shortening the chest pain-to-reperfusion time to less than 240 minutes

264 but the value of resting CTP (rCTP) in acute chest pain triage remains unclear.

265 were infusion reactions (four [11%] of 37), chest pain (two [5%] of 37), haemolysis (two [5%] of 37)

266 the value of CAC scan in patients with acute chest pain undergoing CCTA.

267 In patients with acute chest pain undergoing coronary CTA, cost-efficient testi

268 ion of hard events of SE incorporated into a chest pain unit for patients admitted with acute chest p

269 SE incorporated into a chest pain unit has excellent feasibility and provides r

270 r, such as in a stress testing laboratory or chest pain unit.

271 This is the first reported case of chest pain unrelated to physical activity reported in a

272 rning to the ED within 30 days for recurrent chest pain was 5 times greater with standard evaluation

273 and trismus occurred twice; and non-cardiac chest pain was reported three times.

274 ion (sex and age) on MI presentation without chest pain was significant (P < .001).

275 portion of MI patients who presented without chest pain was significantly higher for women than men (

276 h no steroids, the incidence of pericarditic chest pain was significantly reduced by intrapericardial

277 ong intermediate- to high-risk patients with chest pain, we have shown that a cardiac magnetic resona

278 Both heartburn and chest pain were included in the oesophageal discomfort f

279 s who were undergoing cardiac MR imaging for chest pain were included.

280 Consecutive patients with stable, new onset chest pain were managed by either usual testing (n = 287

281 al of 250 consecutive patients admitted with chest pain, were enrolled in this prospective study.

282 m were reported to have had antemortem acute chest pain, were imaged with postmortem whole-body CT an

283 icity and sensitivity of detecting causes of chest pain, when compared to patient history, clinical f

284 The main side-effect is chest pain, which can be managed with oral analgesics.

285 hough it has been associated with exertional chest pain, which may mimic acute coronary syndrome.

286 re two cases of refractory asthma presenting chest pain, which were successfully treated by using int

287 All patients with chest pain who have an initial hs-cTnT level of <5 ng/l

288 rapid identification of those patients with chest pain who require admission and urgent management a

289 presenting to the emergency department with chest pain who were candidates for stress-first MPI unde

290 nting to the emergency department with acute chest pain will lead to increased downstream testing and

291 ing in contemporary patients who have stable chest pain with a low burden of obstructive CAD, myocard

292 (Better Evaluation of Acute Chest Pain with Computed Tomography Angiography [BEACON]

293 re was a nonsignificant reduced incidence of chest pain with ECG changes with steroids (13.2%, 10.0%,

294 with usual care for the evaluation of stable chest pain with follow-up for cardiovascular outcomes.

295 test clinical data to identify patients with chest pain with normal coronary arteries and no clinical

296 ed sudden onset of epigastric and midsternal chest pain with shortness of breath.

297 d documented preinfarction angina defined as chest pain within 24 hours of infarction.

298 nown diagnostic value in patients with acute chest pain without ACS and is independent of traditional

299 y for evaluation of patients who have stable chest pain without known CAD with intermediate CAD preva

300 f diagnostic strategies for individuals with chest pain without known coronary artery disease (CAD) i